Pulmonx Highlights $12 Billion Global Opportunity for Zephyr Valves in Investor Presentation

Bitget2026/10/27 20:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pulmonx reported third-quarter 2026 revenue of $22.8 million in an investor presentation, with US revenue of $14.9 million.
Gross margin was 76%; cash, cash equivalents and marketable securities totaled $52.7 million as of September 30, 2026.
The presentation estimated a $12 billion global opportunity for Zephyr valves across 1.2 million eligible patients.
Investigational AeriSeal technology could expand the addressable market by at least 20% by making currently ineligible patients eligible for Zephyr treatment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulmonx Corporation published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pulmonx Highlights $12 Billion Global Opportunity for Zephyr Valves in Investor Presentation

You may also like

Crypto prices